COVID-19 and Mental Health in Eure (COVID-SME)

Centre Hospitalier Eure-Seine

Status: Enrolling

Conditions: Psychiatric Disorder; COVID-19 Pandemic

Treatments: Other: Questionnaires

Study type: Observational

Funder types: Other

Identifiers

NCT05364060

2021-A01280-41

CHES N°21/02 (Other Identifier)

Details and patient eligibility

About

Research Hypothesis: Living conditions during COVID-19, and lockdowns and curfews impact the psychological state of patients (assessed by the degree of depression, positive and negative thoughts, insomnia, state of post-traumatic stress).

Full description

From the early stages of the COVID-19 pandemic, concerns were raised about its effect on mental health and on patients with mental illness. Several surveys and cross-sectional assessments, in Italy, England, Ecuador and China in 2020, have suggested that patients with COVID-19 have symptoms of anxiety (including stress disorder traumatic, depression and insomnia.

In France, a survey by "Santé Publique France" on the impact of COVID-19 on mental health carried out in November 2020, revealed a 20% rate of depressive symptoms in the general population.

The objective of this study is to assess the level of psychological distress and the prevalence of psychiatric disorders related to COVID-19 as part of the follow-up of psychiatric patients in the department of Eure since March 2020, which has coincided with the onset of the health crisis, including consecutive lockdowns and curfews.

Enrollment: 585 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• At least 18 years old
• Coming for a psychiatric consultation or hospitalization at the New Hospital of Navarre or in the extra-hospital centers of the department of Eure
• Patient who has received the information note and who does not refuse to participate in the study

Exclusion criteria

• Patient not understanding French
• Patient followed in psychiatry for a major cognitive disorder
• Patient under legal protection measure (guardianship, curatorship, safeguard of justice, future protection mandate or family authorization)

Trial design

585 participants in 1 patient group

patients followed in psychiatry

Description:

Quantitative questionnaires

Treatment:

Other: Questionnaires